Insulin within islets is a physiologic glucagon release inhibitor - sprookjes - yvandenbroek - TriplyDB

Insulin within islets is a physiologic glucagon release inhibitor

Insulin within islets is a physiologic glucagon release inhibitor

http://www.wikidata.org/entity/Q34623723

about

Endocrine regulation of energy metabolism by the skeleton Nutritional modulation of endogenous glucagon-like peptide-1 secretion: a review Tissue-specific deletion of Foxa2 in pancreatic beta cells results in hyperinsulinemic hypoglycemia Preptin derived from proinsulin-like growth factor II (proIGF-II) is secreted from pancreatic islet beta-cells and enhances insulin secretion Artemisinins Target GABAA Receptor Signaling and Impair α Cell Identity Models of glucagon secretion, their application to the analysis of the defects in glucagon counterregulation and potential extension to approximate glucagon action.Pancreatic network control of glucagon secretion and counterregulation.Motivations and methods for analyzing pulsatile hormone secretion Amplification of pulsatile glucagon counterregulation by switch-off of alpha-cell-suppressing signals in streptozotocin-treated rats A K ATP channel-dependent pathway within alpha cells regulates glucagon release from both rodent and human islets of Langerhans.Glucotoxicity induces abnormal glucagon secretion through impaired insulin signaling in InR1G cells Zinc transporters and their role in the pancreatic β-cell.Water sensor ppk28 modulates Drosophila lifespan and physiology through AKH signaling Hyperglucagonemia in an animal model of insulin- deficient diabetes: what therapy can improve it?Binding and internalization of somatostatin, insulin, and glucagon by cultured rat islet cells Glucagon gene transcription is negatively regulated by insulin in a hamster islet cell line.Insulin reciprocally regulates glucagon secretion in humans Paracrinology of islets and the paracrinopathy of diabetes.Intra-islet insulin permits glucose to directly suppress pancreatic A cell function.Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover Regeneration of pancreatic non-β endocrine cells in adult mice following a single diabetes-inducing dose of streptozotocin.Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice Effect of metabolic clearance rate and hepatic extraction of insulin on hepatic and peripheral contributions to hypoglycemia.Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cells.Partial inhibition of insulin secretion results in glucose intolerance but not hyperglucagonemia.Hypothalamic AMP-activated protein kinase activation with AICAR amplifies counterregulatory responses to hypoglycemia in a rodent model of type 1 diabetes.Additive effects of miglitol and anagliptin on insulin-treated type 2 diabetes mellitus: a case study.Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathway Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans A novel GPR40 agonist, CNX-011-67, suppresses glucagon secretion in pancreatic islets under chronic glucolipotoxic conditions in vitro.Loss of fibroblast growth factor 21 action induces insulin resistance, pancreatic islet hyperplasia and dysfunction in mice Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.A pilot study of the efficacy of miglitol and sitagliptin for type 2 diabetes with a continuous glucose monitoring system and incretin-related markers Interaction of the islet nitric oxide system with L-arginine-induced secretion of insulin and glucagon in mice.miR-375 gene dosage in pancreatic β-cells: implications for regulation of β-cell mass and biomarker development Reactive hypoglycaemia following GLP-1 infusion in pancreas transplant recipients.Oestrogens improve human pancreatic islet transplantation in a mouse model of insulin deficient diabetes.Intra-islet glucagon secretion and action in the regulation of glucose homeostasis.Increased fetal insulin concentrations for one week fail to improve insulin secretion or β-cell mass in fetal sheep with chronically reduced glucose supply Paracrine regulation of glucagon secretion: the β/α/δ model.

P2860

Q22337453-73829C51-EAED-4714-AED6-26CF354BA72F Q28070256-0F9B1C91-22B6-4B52-9394-EA659404B46E Q28343716-D1E5461A-192D-4EFC-B8BC-1BAD21E74D90 Q28364649-5F8A0244-2D96-4C92-B6D4-E487C05BC07A Q30365127-A3AE1E3A-3962-4740-B251-596B92B3CB52 Q30429992-AB7834A6-5FA9-43EC-8A76-B1BE332A797D Q30432736-22514250-75E3-4F91-B1EE-7BEFB206B87D Q30437731-E760963E-3317-44DD-B47A-DE2D56F2C685 Q30438739-A4EE53DD-B678-4F2E-9C38-1EA2EFC7EE9B Q33284703-F229DEEB-EA9B-4115-8ACE-AA899DB788CB Q33585517-68583DDD-A582-465E-B767-FBA52E491FCC Q33585706-BADBA0B2-C2D1-499F-91C8-9C931958A888 Q33730420-AFC4642B-94C1-4111-B0BD-811C4B2B7DDD Q33801143-E58C38C1-D263-4C6B-8801-73C2CD45A15A Q33847832-6C8C50C9-DDBC-49CF-8F69-CC57502B3035 Q33848718-1BBFC1B1-EFFB-4578-9299-ED75E1208598 Q34135501-066ED15D-BBD5-4D6E-9197-D60B8B45FDB6 Q34136529-4063B823-84E5-4651-8995-8C0C7ADD85C1 Q34197036-9F8EF7A3-4EC3-4B5C-B89A-FA80133AF4CC Q34244209-E1E4F0B8-2555-46DA-A0DF-65EF0B23B725 Q34269184-8411EFCB-7A22-470F-8998-81CD9A6B7726 Q34526968-6E91623B-B5F1-4717-ACA7-B87299618E64 Q34569198-B5AB1681-3746-489E-AE8D-DA2FB41503FC Q34583696-7386F93C-7F89-4FE6-89B7-BE8E1BB596DF Q34718921-EE744492-66A0-44A6-ABF6-8353B523E60F Q34974852-32CE8315-877F-46A6-A14C-065AEBE2E6EA Q34990233-D885A90A-05FF-4393-9B56-8149E0693E0E Q35134808-DCADB6B5-0CB3-4FE9-BC82-8E49768B2169 Q35179981-4339F206-B5F2-456B-92ED-DD7EFF65490B Q35237844-DAB3E238-84AE-4ACB-9F86-C67550D2FC0F Q35274798-1F622050-743E-4894-BF3C-084A597642DC Q35762651-4DA08AC2-895C-49DD-A548-156D1C1F7CC1 Q35838203-818C4C9C-FD92-46BF-B543-5B86D20857E5 Q35884553-E130B562-5E86-4119-A658-3D72C202CA71 Q36109279-726D650B-F318-4FEF-9280-FB18FB372E83 Q36353347-AEADE1CA-C87C-4B3C-B3F3-9976849F2588 Q36508387-5D683115-88B8-4B78-B488-EB96C6A168F2 Q36516806-1F38D9EE-6190-48DA-82AD-86D4692D106E Q36527989-0F524A39-0044-40A5-B055-58885D0BF2B3 Q36810781-8C782F27-ACD0-426E-BB33-EF97E643A652

P2860

Insulin within islets is a physiologic glucagon release inhibitor

http://www.wikidata.org/entity/Q34623723

description

1984 nî lūn-bûn

@nan

1984 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1984 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

1984年の論文

@ja

1984年論文

@yue

1984年論文

@zh-hant

1984年論文

@zh-hk

1984年論文

@zh-mo

1984年論文

@zh-tw

1984年论文

@wuu

name

Insulin within islets is a physiologic glucagon release inhibitor

@ast

Insulin within islets is a physiologic glucagon release inhibitor

@en

Insulin within islets is a physiologic glucagon release inhibitor

@nl

type

label

Insulin within islets is a physiologic glucagon release inhibitor

@ast

Insulin within islets is a physiologic glucagon release inhibitor

@en

Insulin within islets is a physiologic glucagon release inhibitor

@nl

prefLabel

Insulin within islets is a physiologic glucagon release inhibitor

@ast

Insulin within islets is a physiologic glucagon release inhibitor

@en

Insulin within islets is a physiologic glucagon release inhibitor

@nl

P1433

Q34623723-748A4C64-1B29-41A7-A248-592D626CA237

P1476

Q34623723-FE0DCC35-F99C-497F-982E-BA5002DE4E05

P2093

Q34623723-1768B00B-61C2-4C98-83C8-341E244C7123

Q34623723-4F45194E-FA71-4DBF-8512-E91E2805D196

Q34623723-6FA8BEA6-FAEE-42A7-B9EF-1E0AB3A66465

Q34623723-DBEFE318-C399-4C60-B8D2-B18A3944BBF3

Q34623723-F23D8579-CF90-4D7F-90C8-BC6ED844C7B0

P2860

Q34623723-00BEDDC0-7E6C-43A8-84E0-1DE544CFAA5C

Q34623723-4063A6B3-1B07-4A6D-AFDC-64499FFCC193

Q34623723-775BC95F-58D5-455E-A109-2BD3CF6769D5

Q34623723-9E63E86D-2A2E-48DE-9B54-3A083976B60C

Q34623723-A6E8D21D-D8F0-462D-A196-C77C19913D34

Q34623723-BD770C6B-BCBD-452C-A353-228F23A6974D

Q34623723-EEABE376-CA3C-4D1E-8EBB-46C784057465

Q34623723-F83F70E8-85E6-4E6C-9B25-70C377EA3A37

Q34623723-FAFD7A39-D6B1-4C61-8EBD-8A01CF62A070

P304

Q34623723-BDD9923E-9F37-4296-8ABD-7B37073D1FA7

P31

Q34623723-A86F8D14-FAF1-421A-8DAD-239725711A56

P356

Q34623723-5F3CEF3A-C938-4D46-9C1F-E709339D0290

P407

Q34623723-BAF9C857-C120-44BC-927D-8C0036F1FC24

P433

Q34623723-192CB62F-8302-4F4C-B1B5-A51CAFD362D9

P478

Q34623723-0DEBA467-911B-47A6-B6D9-1E74DC0D4922

P577

Q34623723-382B69E7-7979-40DD-88A2-7E91275B54E9

P698

Q34623723-3B5F9204-FD80-45CC-A849-0E783A1AC36B

P921

Q34623723-D3F8D263-AAC3-417B-9AE4-79A9806AB7C2

P932

Q34623723-72E05ABD-DF92-4434-B062-4594C2051F7D

P356

P1433

Journal of Clinical Investigation

P1476

Insulin within islets is a physiologic glucagon release inhibitor

@en

P2093

A Hisatomi

http://www.w3.org/2001/XMLSchema#string

G M Grodsky

http://www.w3.org/2001/XMLSchema#string

H Maruyama

http://www.w3.org/2001/XMLSchema#string

L Orci

http://www.w3.org/2001/XMLSchema#string

R H Unger

http://www.w3.org/2001/XMLSchema#string

P2860

Immunoassay of endogenous plasma insulin in man

The effect of experimental insulin deficiency on glucagon secretion.

Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics

Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia.

Studies of pancreatic alpha cell function in normal and diabetic subjects.

In vivo inhibition of glucagon secretion by paracrine beta cell activity in man.

Pancreatic action of the sulfonylureas.

Possible roles of the pancreatic D-cell in the normal and diabetic states.

Insulin control of glucagon release from insulin-deficient rat islets.

P304

2296-2299

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI111658

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P577

1984-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

6392344

http://www.w3.org/2001/XMLSchema#string

P921

P932

425424

http://www.w3.org/2001/XMLSchema#string